Company Profile
Homology Medicines Stock Price, News & Analysis
- Ticker:
- FIXX
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
16.82 USD
Close
Last updated: March 25, 2024 at 00:00
—
Market cap
Why the stock is moving
FIXX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Homology Medicines is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Homology Medicines is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Homology Medicines follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Homology Medicines sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 02
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 03
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Homology Medicines (FIXX)?
Homology Medicines (FIXX) most recently closed at 16.82 USD.
What does Homology Medicines do?
Homology Medicines is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is FIXX stock listed?
Homology Medicines (FIXX) is associated with NASDAQ, United States, Biotechnology.
What is Homology?
Homology Medicines is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Homology Medicines targeting with Homology?
Homology Medicines is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Medicines?
Homology Medicines is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.